Heparanase regulates EMT and cancer stem cell properties in prostate tumors

Prostate cancer displays a certain phenotypic plasticity that allows for the transition of cells from the epithelial to the mesenchymal state. This process, known as epithelial–mesenchymal transition (EMT), is one of the factors that give the tumor cells greater invasive and migratory capacity with...

Full description

Bibliographic Details
Main Authors: Valentina Masola, Marco Franchi, Gianluigi Zaza, Francesca Mansa Atsina, Giovanni Gambaro, Maurizio Onisto
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2022.918419/full
_version_ 1818161925016518656
author Valentina Masola
Marco Franchi
Gianluigi Zaza
Francesca Mansa Atsina
Giovanni Gambaro
Maurizio Onisto
author_facet Valentina Masola
Marco Franchi
Gianluigi Zaza
Francesca Mansa Atsina
Giovanni Gambaro
Maurizio Onisto
author_sort Valentina Masola
collection DOAJ
description Prostate cancer displays a certain phenotypic plasticity that allows for the transition of cells from the epithelial to the mesenchymal state. This process, known as epithelial–mesenchymal transition (EMT), is one of the factors that give the tumor cells greater invasive and migratory capacity with subsequent formation of metastases. In addition, many cancers, including prostate cancer, are derived from a cell population that shows the properties of stem cells. These cells, called cancer stem cells (CSCs) or tumor-initiating cells, not only initiate the tumor process and growth but are also able to mediate metastasis and drug resistance. However, the impact of EMT and CSCs in prostate cancer progression and patient survival is still far from fully understood. Heparanase (HPSE), the sole mammalian endoglycosidase capable of degrading heparan sulfate (HS), is also involved in prostate cancer progression. We had previously proved that HPSE regulates EMT in non-cancerous pathologies. Two prostate cancer cell lines (DU145 and PC3) were silenced and overexpressed for HPSE. Expression of EMT and stemness markers was evaluated. Results showed that the expression of several EMT markers are modified by HPSE expression in both the prostate cancer cell lines analyzed. In the same way, the stemness markers and features are also modulated by HPSE expression. Taken together, the present findings seem to prove a new mechanism of action of HPSE in sustaining prostate cancer growth and diffusion. As for other tumors, these results highlight the importance of HPSE as a potential pharmacological target in prostate cancer treatment.
first_indexed 2024-12-11T16:25:30Z
format Article
id doaj.art-70a4608fcd794b358b7e240bcf57cd4c
institution Directory Open Access Journal
issn 2234-943X
language English
last_indexed 2024-12-11T16:25:30Z
publishDate 2022-07-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj.art-70a4608fcd794b358b7e240bcf57cd4c2022-12-22T00:58:45ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2022-07-011210.3389/fonc.2022.918419918419Heparanase regulates EMT and cancer stem cell properties in prostate tumorsValentina Masola0Marco Franchi1Gianluigi Zaza2Francesca Mansa Atsina3Giovanni Gambaro4Maurizio Onisto5Department of Biomedical Sciences, University of Padova, Padova, ItalyDepartment of Life Quality Sciences, University of Bologna, Rimini, ItalyDepartment of Medical and Surgical Sciences, University of Foggia, Foggia, ItalyUniversity Hospital of Verona, Verona, ItalyRenal Unit, Department of Medicine, University Hospital of Verona, Verona, ItalyDepartment of Biomedical Sciences, University of Padova, Padova, ItalyProstate cancer displays a certain phenotypic plasticity that allows for the transition of cells from the epithelial to the mesenchymal state. This process, known as epithelial–mesenchymal transition (EMT), is one of the factors that give the tumor cells greater invasive and migratory capacity with subsequent formation of metastases. In addition, many cancers, including prostate cancer, are derived from a cell population that shows the properties of stem cells. These cells, called cancer stem cells (CSCs) or tumor-initiating cells, not only initiate the tumor process and growth but are also able to mediate metastasis and drug resistance. However, the impact of EMT and CSCs in prostate cancer progression and patient survival is still far from fully understood. Heparanase (HPSE), the sole mammalian endoglycosidase capable of degrading heparan sulfate (HS), is also involved in prostate cancer progression. We had previously proved that HPSE regulates EMT in non-cancerous pathologies. Two prostate cancer cell lines (DU145 and PC3) were silenced and overexpressed for HPSE. Expression of EMT and stemness markers was evaluated. Results showed that the expression of several EMT markers are modified by HPSE expression in both the prostate cancer cell lines analyzed. In the same way, the stemness markers and features are also modulated by HPSE expression. Taken together, the present findings seem to prove a new mechanism of action of HPSE in sustaining prostate cancer growth and diffusion. As for other tumors, these results highlight the importance of HPSE as a potential pharmacological target in prostate cancer treatment.https://www.frontiersin.org/articles/10.3389/fonc.2022.918419/fullprostate cancerheparanaseepithelial to mesenchymal transitioncancer stem cellsin vitro
spellingShingle Valentina Masola
Marco Franchi
Gianluigi Zaza
Francesca Mansa Atsina
Giovanni Gambaro
Maurizio Onisto
Heparanase regulates EMT and cancer stem cell properties in prostate tumors
Frontiers in Oncology
prostate cancer
heparanase
epithelial to mesenchymal transition
cancer stem cells
in vitro
title Heparanase regulates EMT and cancer stem cell properties in prostate tumors
title_full Heparanase regulates EMT and cancer stem cell properties in prostate tumors
title_fullStr Heparanase regulates EMT and cancer stem cell properties in prostate tumors
title_full_unstemmed Heparanase regulates EMT and cancer stem cell properties in prostate tumors
title_short Heparanase regulates EMT and cancer stem cell properties in prostate tumors
title_sort heparanase regulates emt and cancer stem cell properties in prostate tumors
topic prostate cancer
heparanase
epithelial to mesenchymal transition
cancer stem cells
in vitro
url https://www.frontiersin.org/articles/10.3389/fonc.2022.918419/full
work_keys_str_mv AT valentinamasola heparanaseregulatesemtandcancerstemcellpropertiesinprostatetumors
AT marcofranchi heparanaseregulatesemtandcancerstemcellpropertiesinprostatetumors
AT gianluigizaza heparanaseregulatesemtandcancerstemcellpropertiesinprostatetumors
AT francescamansaatsina heparanaseregulatesemtandcancerstemcellpropertiesinprostatetumors
AT giovannigambaro heparanaseregulatesemtandcancerstemcellpropertiesinprostatetumors
AT maurizioonisto heparanaseregulatesemtandcancerstemcellpropertiesinprostatetumors